Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Med.

Sec. Pulmonary Medicine

Volume 12 - 2025 | doi: 10.3389/fmed.2025.1582913

The Predictive Value of D-dimer Combined with Systemic Immune-Inflammation Index for the Presence of Pulmonary Thromboembolism in AECOPD Patients

Provisionally accepted
Xuanna  ZhaoXuanna ZhaoJiahua  LiJiahua Li*Yunan  WangYunan WangBangxiao  HuangBangxiao HuangXiaobing  XieXiaobing XieMin  ChenMin ChenBin  WuBin WuDan  HuangDan HuangDongming  LiDongming LiDong  WuDong Wu
  • Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong Province, China

The final, formatted version of the article will be published soon.

This study aims to evaluate the predictive potential of D-dimer levels and the systemic immune-inflammatory index (SII) for identifying concurrent pulmonary thromboembolism (PTE) in patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD). We conducted a case-control study involving 75 patients with AECOPD and concurrent PTE, admitted to the Affiliated Hospital of Guangdong Medical University between June 2017 and December 2020. A control group comprising 76 AECOPD patients without PTE was included for comparison. Clinical characteristics and laboratory findings were compared between the two groups. Multivariate logistic regression was employed to identify independent risk factors for PTE in AECOPD patients. The predictive accuracy of these risk factors was assessed using receiver operating characteristic (ROC) curves, while Spearman correlation analysis evaluated associations between variables. Model robustness was validated internally using bootstrap techniques, and decision curve analysis (DCA) was applied to determine the clinical utility of the predictive model. Multivariate logistic regression identified D-dimer [odds ratio (OR) 1.17, 95% confidence interval (CI) 1.03–1.38] and the SII (OR 1.003, 95% CI 1.000–1.006) as independent risk factors for PTE in patients with AECOPD. The area under the ROC curve (AUC) values for predicting PTE in AECOPD patients were 0.758 (95% CI 0.682–0.834) for D-dimer, 0.757 (95% CI 0.677–0.838) for SII, and 0.834 (95% CI 0.768–0.900) for their combination, respectively. The Bootstrap results demonstrated that the model combining D-dimer and SII had an AUC of 0.8409 (95% CI: 0.7649, 0.9156), indicating robust performance across resampled datasets. Both D-dimer and SII showed a positive correlation with hospital stay duration (r = 0.289, P = 0.047; r = 0.235, P = 0.043). DCA demonstrated that the combination of D-dimer and SII provides significant net benefit in clinical decision-making for predicting PTE in AECOPD patients. D-dimer and SII are independent risk factors for predicting concurrent PTE in AECOPD patients. The combination of these two markers demonstrates robust predictive accuracy, and their levels may be positively correlated with disease severity. These findings suggest that D-dimer and SII could play a valuable role in clinical decision-making and risk stratification in AECOPD patients.

Keywords: Acute exacerbations of chronic obstructive pulmonary disease, pulmonary thromboembolism, d-dimer, Systemic immune inflammatory index, predictive model

Received: 25 Feb 2025; Accepted: 21 Jul 2025.

Copyright: © 2025 Zhao, Li, Wang, Huang, Xie, Chen, Wu, Huang, Li and Wu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Jiahua Li, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong Province, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.